Abstract
Background: Studies suggest that the anal sphincter can be preserved in some patients with distal rectal adenocarcinoma (DRA), but this has not been validated in any prospective multi-institutional trial.
Methods: To test the hypothesis that the anal sphincter can be preserved in some patients with DRA, the Cancer and Leukemia Group B and collaborators reviewed 177 patients who had T1/T2 adenocarcinomas ≤ 4 cm in diameter, which encompassed ≤ 40% of bowel wall circumference, and were ≤ 10 cm from the dentate line. Of the 177 patients, 59 patients who were eligible for the study had T1 adenocarcinomas and received no further treatment; 51 eligible T2 patients received external beam irradiation (5400 cGY/30 fractions 5 days/week) and 5-fluorouracil (500 mg/m2 IV d1–3, d29–31) after local excision.
Results: At 48 months median follow-up, 6-year survival and failure-free survival rates of the eligible patients are 85% and 78% respectively. Three patients died of unrelated disease. Two patients were treated for second primary colorectal tumors; both remain disease free (NED). Another eight patients died of disease, four with distant recurrence only. One T1 patient is alive with distant disease. Two T1 and seven T2 patients experienced isolated local recurrences; all underwent salvage abdominoperineal resection (APR). After APR, one T1 and four of seven T2 patients were NED at the time of last visit (2–7 years). One T1 patient died of local and distant disease. Three of seven T2 patients died with distant disease.
Conclusions: We conclude that sphincter preservation can be achieved with excellent cancer control without initial sacrifice of anal function in most patients. After local recurrence, salvage resection appears effective, but longer follow-up time of local and distant disease-free survival is advised before extrapolation to patients with T3 primaries.
REFERENCES
Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999;1:8–31.
Hertz RE, Reddish MR, Day E. Value of periodic examination in detecting cancer of the rectum and colon. Postgrad Med 1960;27:290–4.
Gilbertsen VA. Proctosigmoidoscopy and polypectomy in reducing the incidence of rectal cancer. Cancer 1974;34:936–9.
Winawer SJ, Zauber AG, Gerdes H, et al. Risk of colorectal cancer in the families of patients with adenomatous polyps: Nation Polyp Study Workgroup. N Engl J Med 1996;334(2):82–7.
Miles WE. A method of performing abdominoperineal excision for carcinoma of the rectum and the terminal portion of the pelvic colon. Cancer 1908;2:1812.
Evans JT, Vana J, Aronoff BL. Management and survival of carcinoma of the colon: results of a national survey of the ACS. Ann Surg 1978;188:716–20.
Biggers OR, Beart RWJr., Ilstrup DM. Local excision of rectal cancer. Dis Colon Rectum 1986;29:374–7.
GITSG. Prolongaton of the disease-free interval in surgically treated rectal cancer. N Engl J Med 1985;312:1465–72.
Heald RJ, Ryall RDH. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986;1:1479–82.
Madden JL, Kandarafts A. Electrocoagulation in the treatment of cancer of the rectum. Ann Surg 1971;174:530–8.
Hoeksta HJ, Verschueven TCJ, Oldhoff J, Ploeg EVD. Palliative and curative electrocoagulation for rectal cancer: experience and results. Cancer 1985;55:210–3.
Mason AY. Transsphincteric approach to rectal lesion. Surg Ann 1974;9:171–94.
Bleday R, Breen E, Jessup JM, Burgess A, Sentovich SM, Steele GJr. Prospective evaluation of local excision for small rectal cancers. Dis Colon Rectum 1997;40:488–392.
Papillon, J. Rectal and anal cancers: conservative treatment by irradiation, an alternative to radical surgery. Berlin: Springer-Verlag, 1982.
Sischy B, Remington JE, Sabel SE. Treatment of rectal carcinomas by means of endocavitary irradiation: a progress report. Cancer 1980;46:1957–61.
Syed AM, Feder BH. Technique of after-loading interstated implants. Radiol Clin (Basel) 1977;46:458–75.
Steele GDJr, Busse P, Huberman MS, et al. A pilot study of sphincter sparing management of adenocarcinoma of the rectum. Arch Surg 1991;126:696–702.
Bleday R, Steele GJr. Adjuvant therapy after local excision for rectal cancer. Semin Colon Rect Surg 1996;7:55–9.
Steele GJr., Tepper J, Hernon J, Mayer R. Failure and salvage after sphincter sparing treatment for distal rectal adenocarcinoma. Proc ASCO 1999;18:235.
Jessup JM, Stewart AK, Menck HR. The National Cancer Data Base report on patterns of care for adenocarcinoma of the rectum, 1985–1995. Cancer 1998;83:2408–10.
Cox DR. Regression models and life-tables. J R Stat Soc 1972;34:187–220.
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457–81.
O’Connell MJ, Rich TA, Steele GJr. Low rectal ca: sphinctersparing strategies. Patient Care 1991;25:32–48.
Steele GJr, Herndon JE, Burgess AM, et al. Sphincter sparing treatment for distal rectal adenocarcinoma: a phase II intergroup study. Proc ASCO 1997;16:256a.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Steele, G.D., Herndon, J.E., Bleday, R. et al. Sphincter-Sparing Treatment for Distal Rectal Adenocarcinoma. Ann Surg Oncol 6, 433–441 (1999). https://doi.org/10.1007/s10434-999-0433-5
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10434-999-0433-5